Enzyme replacement therapy lowers forearm and hand compliance in Fabry patients

被引：0
|
作者：
Hilz, M. J. [1 ,2 ]
Kolodny, E. H. [1 ]
Marthol, H. [2 ]
机构：
[1] NYU, Dept Neurol, New York, NY 10016 USA
[2] Univ Erlangen Nurnberg, Dept Neurol, D-8520 Erlangen, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [41] EVALUATION OF RENAL BIOMARKERS FOR FABRY DISEASE PATIENTS WITH AND WITHOUT ENZYME REPLACEMENT THERAPY
    Braga, Marion Coting
    Bacci, Marcelo
    Affonso Fonseca, Fernando Luiz
    Martins, Ana Maria
    D'almeida, Vania
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [42] Cardio-renal syndrome in patients with Fabry disease on enzyme replacement therapy
    Parshina, Ekaterina
    Prokopenko, Elena
    Zulkarnaev, Aleksei
    Popov, Mikhail
    Kotalevskaya, Yulia
    Shumakov, Dmitry
    Gubina, Daria
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2277 - I2279
  • [43] Access to enzyme replacement therapy and to ancillary tests in Brazilian Fabry disease patients
    Rosa Neto, Nilton S.
    Bento, Judith C. B.
    Pereira, Rosa Maria R.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S138 - S138
  • [44] Consensus recommendations on initiation and cessation of enzyme replacement therapy in patients with Fabry disease
    Biegstraaten, Marieke
    Hollak, Carla E. M.
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S23 - S23
  • [45] Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature
    Pisani, Antonio
    Visciano, Bianca
    Roux, Graciana Diez
    Sabbatini, Massimo
    Porto, Caterina
    Parenti, Giancarlo
    Imbriaco, Massimo
    MOLECULAR GENETICS AND METABOLISM, 2012, 107 (03) : 267 - 275
  • [46] Clinical features after enzyme replacement therapy in hemodialysis patients with Fabry disease
    Tanaka, M.
    Itoh, K.
    Matsushita, K.
    Matsushita, K.
    Yasumoto, N.
    Ohashi, T.
    Kobayashi, M.
    Eto, Y.
    Nonoguchi, H.
    Tomita, K.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 133 - 133
  • [47] Aberrant DNAmethylation of calcitonin receptor in Fabry patients treated with enzyme replacement therapy
    Hubner, Anna
    Metz, Thomas
    Schanzer, Andrea
    Greber-Platzer, Susanne
    Item, Chike Bellarmine
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 5 : 1 - 2
  • [48] Enzyme replacement therapy improves cardiovascular responses to orthostatic challenge in Fabry patients
    Hilz, Max J.
    Marthol, Harald
    Schwab, Stefan
    Kolodny, Edwin H.
    Brys, Miroslaw
    Stemper, Brigitte
    JOURNAL OF HYPERTENSION, 2010, 28 (07) : 1438 - 1448
  • [49] Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy
    Dutra-Clarke, Marina
    Tapia, Daisy
    Curtin, Emily
    Ruenger, Dennis
    Lakatos, Anita
    Alandy-Dy, Zyza
    Freedkin, Linda
    Hall, Kathy
    Ercelen, Nesrin
    Alandy-Dy, Jousef
    Knight, Margaret
    Pahl, Madeline
    Lombardo, Dawn
    Kimonis, Virginia
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S36 - S36
  • [50] Enzyme replacement therapy improves skin blood flow control in Fabry patients
    Hilz, M. J.
    Kolodny, E. H.
    Marthol, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 49 - 49
12345